DI MAURO, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 228
EU - Europa 143
AS - Asia 87
SA - Sud America 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 466
Nazione #
US - Stati Uniti d'America 228
IT - Italia 45
SE - Svezia 44
SG - Singapore 39
IN - India 23
CN - Cina 22
FI - Finlandia 16
RO - Romania 6
AT - Austria 5
AR - Argentina 4
NL - Olanda 4
RU - Federazione Russa 4
UA - Ucraina 4
DE - Germania 3
FR - Francia 3
IL - Israele 3
EG - Egitto 2
GB - Regno Unito 2
IE - Irlanda 2
BE - Belgio 1
BG - Bulgaria 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
ZA - Sudafrica 1
Totale 466
Città #
Chandler 36
Singapore 31
Rome 23
Fairfield 21
Santa Clara 15
Beijing 13
Princeton 12
Ashburn 11
Plano 11
Woodbridge 9
Boston 8
Des Moines 7
Seattle 7
Cambridge 6
Lawrence 6
Ann Arbor 5
San Paolo di Civitate 5
Vienna 5
Dearborn 4
Federal 4
Helsinki 4
Moscow 4
Wilmington 4
Houston 3
Nanjing 3
New York 3
San Diego 3
Baraq 2
Brooklyn 2
Chicago 2
Cixi 2
Dublin 2
Guangzhou 2
Jacksonville 2
Mannheim 2
Peccioli 2
Tala 2
West Hartford 2
Amsterdam 1
Andover 1
Athens 1
Bern 1
Brussels 1
Galdo 1
Havant 1
Hounslow 1
Jiaxing 1
Millbury 1
Muizenberg 1
Norwalk 1
Salt Lake City 1
San Mateo 1
Sofia 1
West Islip 1
Totale 301
Nome #
null 49
Congenital FXI deficiency: evaluation of bleeding phenotype and correlation with FXI activity (FXI:Act) 45
Acquired haemophilia A (AHA): clinical features and management of patients from a single center. 44
Subclinical cochlear dysfunction in newly diagnosed relapsing-remitting multiple sclerosis 44
Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: Results of a retrospective study from a single centre 40
Sustained response after thrombopoietin receptor agonists discontinuation in 5 patients affected by primary immune thrombocytopenia 37
Correlation of bleeding phenotype/FXI activity (FXI:Act) in congenital FXI deficiency. 35
Thrombopoietin receptor agonists in primary immune thrombocytopenia: Evaluation of efficacy (response and sustained response off-treatment) and safety in a single center population. 35
Diagnosis and management of acquired hemophilia A (AHA) patients: experience of a single center 32
Correlation of bleeding phenotype/FXI activity (FXI:Act) in congenital FXI deficiency 32
Congenital FXI deficiency: evaluation of bleeding phenotype and correlation with FXI activity (FXI:Act). 30
Diagnosis and management of acquired haemophilia A (AHA) patients: experience of a single center 30
Sustained response after thrombopoietin receptor agonists discontinuation in 5 patients affected by primary immune thrombocytopenia 25
Totale 478
Categoria #
all - tutte 1.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 0 6 5 5 5 8 3 4
2020/202114 0 3 2 3 0 0 0 3 1 1 1 0
2021/2022102 0 6 4 6 17 14 1 6 12 9 5 22
2022/2023126 18 29 10 10 7 20 9 4 14 0 2 3
2023/202464 4 10 7 8 7 4 5 2 0 6 5 6
2024/202561 2 19 2 3 25 10 0 0 0 0 0 0
Totale 478